MS
Morgan Stanley · Financials · Capital Markets
Last
$217.71
+$7.57 (+3.60%) 11:41 AM ET
Prev close $210.14
Open $212.08
Day high $218.37
Day low $211.46
Volume 1,727,856
Avg vol 5,423,009
Mkt cap
$339.08B
P/E ratio
19.72
FY Revenue
$123.68B
EPS
11.04
Gross Margin
59.42%
Sector
Financials
AI report sections
MS
Morgan Stanley
Morgan Stanley combines moderate revenue growth with faster net income and EPS expansion, supported by double-digit margins and solid returns on equity. The share price is trading near the upper end of its 52-week range with strong 6–12 month price performance and a neutral-to-balanced technical profile, while short interest remains low. Key risks include negative free cash flow, elevated leverage, and a valuation that appears rich relative to cash generation.
AI summarized at 12:29 AM ET, 2026-01-29
AI summary scores
INTRADAY: 58 SWING: 67 LONG: 63
Volume vs average
Intraday (cumulative)
−1% (Below avg)
Vol/Avg: 0.99×
RSI
69.27 (Strong)
Strong (60–70)
MACD momentum
Intraday
-0.16 (Weak)
MACD: -0.01 Signal: 0.15
Short-Term
+1.08 (Strong)
MACD: 6.71 Signal: 5.63
Long-Term
+1.12 (Strong)
MACD: 10.93 Signal: 9.80
Intraday trend score 62.57

Latest news

MS 12 articles Positive: 1 Neutral: 11 Negative: 0
Neutral The Motley Fool • Adria Cimino
Want to Buy SpaceX on IPO Day? Here's How.

SpaceX is preparing for what could be the largest IPO ever, with an expected valuation near $2 trillion and an IPO date around June 12. Unlike typical IPOs where institutional investors dominate, SpaceX plans to allocate approximately 30% of shares to retail investors through brokerages including Charles Schwab, Fidelity, Robinhood, and SoFi. The article advises cautious investors to wait and consider safer entry points, while aggressive investors may find growth opportunities, though the company is currently unprofitable due to heavy spending on AI development.

SCHW SCHWPD SCHWPJ HOOD SpaceX IPO retail investors initial public offering space launches
Sentiment note

Referenced for its E*TRADE platform potentially offering SpaceX shares. No sentiment expressed.

Neutral The Motley Fool • Billy Duberstein
Why AppLovin Rallied in May

AppLovin stock surged 37.4% in May following strong Q1 earnings that beat expectations with 58.6% revenue growth and 69.5% EPS growth. The rally was further boosted by a prominent hedge fund manager pitching the stock at the Sohn Investment Conference, predicting a $1 trillion valuation within seven years. Sell-side analysts also turned positive, highlighting the company's strong moat in mobile gaming advertising and potential for AI-driven conversion rate improvements.

APP MS MSPA MSPE AppLovin earnings beat revenue growth mobile gaming advertising
Sentiment note

Mentioned as a sell-side analyst firm that wrote a positive note on AppLovin, but the article focuses on AppLovin's performance rather than Morgan Stanley's business or outlook.

Neutral The Motley Fool • Scott Levine
Why IonQ Stock Skyrocketed 59.7% in May

IonQ stock surged nearly 60% in May following strong Q1 2026 results, with revenue of $64.7 million exceeding expectations and a turnaround to $2.07 EPS profit. The company raised its 2026 revenue guidance to $260-270 million (104% YoY growth) and announced presales of its next-generation 256-qubit quantum computing system. Analysts JPMorgan and Morgan Stanley raised their price targets, though the stock remains more reasonably valued than competitors.

IONQ IONQ.WS AMJB JPM quantum computing Q1 2026 earnings revenue guidance 256-qubit system
Sentiment note

Mentioned as an analyst that raised IonQ price target; no direct company performance information provided.

Neutral The Motley Fool • Dave Kovaleski
Bank Stress Tests Are Coming in Late June. These Big Banks Could Reward Shareholders Next.

The Federal Reserve will release bank stress test results in late June 2026. Unlike last year when buffers decreased significantly, the Fed has frozen stress capital buffers for 2026, meaning results won't change regardless of performance. This freeze allows banks to maintain reduced capital cushions from 2025, freeing up funds for shareholder rewards like dividends and buybacks. However, poor stress test results could still dampen investor sentiment and capital return plans.

AMJB JPM JPMPC JPMPD stress tests Federal Reserve capital buffers dividends
Sentiment note

Buffer reduced but not to minimum in 2025; frozen buffers for 2026 support dividends and buybacks; history of Q3 dividend increases since 2020, but lower valuations year-to-date present mixed signals.

Neutral Benzinga • Namrata Sen
Softbank's Masayoshi Son Isn't Worried About An AI Bubble— He's Hunting For The Next Trillion-Dollar Industry: 'Just The Beginning'

SoftBank CEO Masayoshi Son believes the AI revolution is '50x bigger' than the dot-com boom and will last 50-100 years, dismissing concerns of an AI bubble. Son has identified humanoid and industrial robotics with 'physical AI' as the next trillion-dollar opportunity, evidenced by SoftBank's $5.4 billion acquisition of ABB's robotics division in October and plans for a $100 billion IPO of its Roze AI venture.

SFTBY ABBNY META GS AI revolution humanoid robotics industrial robotics physical AI
Sentiment note

Morgan Stanley is mentioned as an underwriter for Roze AI's IPO and projects the robotics market reaching $5 trillion by 2050, but the article provides no sentiment-specific information about the company itself.

Neutral The Motley Fool • Thomas Niel
This $12 Stock Has 10X Potential, According to Wall Street

Joby Aviation (JOBY), an eVTOL pioneer, is rebounding after a significant decline from its $21 peak. The company beat Q1 revenue expectations and plans its first commercial launch in 2026, including U.S. and Dubai services. Analysts project the stock could reach $18 in the near term, with potential for 10x returns long-term as the eVTOL market could reach $1.5 trillion by 2040.

JOBY JOBY.WS MS MSPA eVTOL electric vertical takeoff and landing urban mobility flying taxi
Sentiment note

Mentioned only as source of industry research/white paper on eVTOL market potential; no direct sentiment regarding the company itself.

Neutral The Motley Fool • Keith Noonan
Why Microsoft Stock Is Surging Today

Microsoft stock surged 3.4% on Thursday following positive analyst coverage from Morgan Stanley on its cloud infrastructure expansion, a $9.69 billion Department of Defense contract awarded to Dell that includes Microsoft software and cloud services, and reports of upcoming AI applications including a new coding model at next week's Build conference. Despite the gains, the stock remains down approximately 12% year to date.

MSFT DELL MS MSPA Microsoft cloud infrastructure AI applications coding model Department of Defense contract
Sentiment note

Published bullish analyst coverage on Microsoft's cloud business prospects, but as an analyst firm rather than a direct beneficiary of the news, sentiment is neutral regarding the firm itself.

Neutral Benzinga • Prnewswire
Electrolux Group publishes prospectus for the Rights Issue

Electrolux Group announced the approval of its prospectus by the Swedish Financial Supervisory Authority for a fully underwritten rights issue of approximately SEK 9 billion. The rights issue was approved by an Extraordinary General Meeting on May 27, 2026, with Morgan Stanley and SEB acting as Joint Global Coordinators and Deutsche Bank as Co-Bookrunner.

MS MSPA MSPE MSPF rights issue prospectus capital raise SEK 9 billion
Sentiment note

Morgan Stanley's role as Joint Global Coordinator is a routine advisory engagement that generates fees but provides no indication of positive or negative sentiment regarding the underwriting mandate itself.

Neutral Benzinga • Badar Shaikh
Ross Gerber Backs SpaceX IPO Following Successful Starship V3 Test Launch: 'Perfect Timing For...'

Investor Ross Gerber has endorsed SpaceX's upcoming IPO following a successful Starship rocket test launch, calling it 'perfect timing.' SpaceX plans to allocate up to 30% of shares to retail investors through platforms like Robinhood and SoFi, with Goldman Sachs and Morgan Stanley serving as lead underwriters. However, some experts warn the IPO could negatively impact Tesla investors by diverting CEO Elon Musk's attention.

GS GSPA GSPC GSPD SpaceX IPO Starship test launch retail investors Elon Musk
Sentiment note

Playing key role as investment bank in SpaceX IPO listing; represents business opportunity but no direct operational impact

Neutral Benzinga • Badar Shaikh
Top Analyst Predicts Initial 'Pop' For SpaceX Investors Following IPO Due To Nasdaq 100, S&P 500 Boost—Questions $2 Trillion Market Cap

Investor Gary Black predicts SpaceX could see an initial price surge following its IPO due to Nasdaq-100 and S&P 500 inclusion, low float percentage, and strong underwriter distribution. However, Black questions the company's $2 trillion valuation, citing concerns about its 300x EBITDA multiple and lack of profitability relative to its market cap. The IPO could also potentially divert attention and investment from Tesla.

TSLA GS GSPA GSPC SpaceX IPO valuation concerns Nasdaq-100 S&P 500
Sentiment note

Mentioned as co-lead underwriter for SpaceX IPO with distribution capabilities, but this is a transactional role without direct impact on the firm's core business.

Positive Benzinga • Badar Shaikh
Tesla Investor Shares How Retail Investors Can Participate In Blockbuster SpaceX IPO Via Robinhood, Sofi

SpaceX is preparing for its IPO with plans to allocate up to 30% of shares to retail investors through platforms like Robinhood, SoFi, E-TRADE, Charles Schwab, and Fidelity. Each platform has different minimum account balance requirements ranging from none to $500,000. Goldman Sachs is leading the IPO as underwriter, with Morgan Stanley in a key position. BlackRock is considering a $5-10 billion investment in the space company.

HOOD SOFI SCHW SCHWPD SpaceX IPO retail investors brokerage platforms share allocation
Sentiment note

Positioned in a key role for the SpaceX IPO, providing investment banking services and advisory support for a major, high-profile transaction.

Neutral GlobeNewswire Inc. • Na
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock

Immix Biopharma closed an underwritten registered offering of 16.78 million shares at $8.94 per share, raising approximately $140.65 million in net proceeds. The financing was led by Morgan Stanley and BofA Securities, with participation from leading U.S. biotechnology institutional investors and mutual funds.

IMMX MS MSPA MSPE capital raise underwritten offering biotech financing AL Amyloidosis
Sentiment note

Acted as lead book-running manager for the offering. This represents standard investment banking activity with no material impact on the firm's operations or financial performance.

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal